Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

676 North St. Clair Street, 21st Floor, Chicago, IL 60611 - USA
Maggie Daley Center for Women’s Cancer Care, Prentice Women's Hospital
250 E Superior, 4th Floor, Chicago, IL 60611 - USA

First established at Northwestern University in 1974, the center was dedicated as the Robert H. Lurie Cancer Center of Northwestern University in 1991 through a gift of endowment from Ann and Robert H. Lurie. The center’s title was modified in 1997, when the National Cancer Institute (NCI) awarded the Lurie Cancer Center the “comprehensive” designation, reflecting the center’s dedication to the highest standards of cancer research, patient care, education, and community outreach.

Today, the Lurie Cancer Center is one of only 41 NCI-designated “comprehensive” cancer centers in the nation. In addition, the Lurie Cancer Center is a founding member of the National Comprehensive Cancer Network (NCCN), an alliance of 25 of the world’s leading cancer centers dedicated to improving the quality and effectiveness of care provided to patients with cancer. It also is part of the Big Ten Cancer Research Consortium, a network of academic institutions working together on highly translational clinical trials using the expertise of Big Ten universities.

The Lurie Cancer Center is affiliated with four teaching hospitals in Chicago — Northwestern Memorial Hospital, Ann & Robert H. Lurie Children’s Hospital of Chicago, the Rehabilitation Institute of Chicago, and the Jesse Brown Veteran’s Affairs Medical Center – treating more than 10,000 new cancer cases each year.

Website: Robert H. Lurie Comprehensive Cancer Center

Contact:
Cary Passaglia, CCRP
312-695-1378

Trials at this location:

GU16-260

Phase II study of front line therapy with nivolumab and salvage nivolumab + ipilimumab in patients with advanced renal cell carcinoma

Status: Open to Accrual
Read More

LUN13-175

A Phase I/II Study of Carboplatin/Nab-Paclitaxel and MK-3475 for Advanced Non-Small Cell Lung Cancer (NSCLC): HCRN LUN13-175

Status: Open to Accrual
Read More